The Latest Breaking News from Brickell Biotech

Brickell Biotech (NASDAQ:BBI) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Brickell Biotech will report an earnings per share (EPS) of $-0.06.

Brickell Biotech Inc (NASDAQ:BBI) agreed to sell sofpironium bromide rights to Australia-based Botanix Pharmaceuticals Limited. Brickell will receive upfront and potential near-term regulatory milestone payments over the next 18 months of up to $9 million. Brickell also is eligible to receive additional milestone payments of up to $168 million and tiered earn-out payments ranging from high-single…

 

Brickell Biotech (NASDAQ:BBI) is set to give its latest quarterly earnings report on Tuesday, 2022-03-15. Here's what investors need to know before the announcement. Analysts estimate that Brickell Biotech will report an earnings per share (EPS) of $-0.08.